FDD-based analysis. Item-level data. No franchisor input.
Mold Medics franchises air quality and environmental services businesses offering mold testing, mold remediation, duct and vent cleaning, water damage dry-outs, restoration work such as drywall repair and painting, ozone and odor treatments, and attic insulation and sealing. A franchisee serves customer locations within a specified geographic territory, operating from a designated business office that may be home-based where local law allows.
Source: Franchise Disclosure Document, rewritten by Zorzee
Every value here comes straight from the FDD; anything not yet source-verified stays blank rather than estimated. The Pro figures and full interpretation unlock with a Pro membership.
Every data point Zorzee tracks for this brand, in FDD Item order. Missing source data stays blank; Pro-only interpretation remains locked.
| Item | Data Point | Value | Source |
|---|---|---|---|
| Item 3 | Litigation Actions (total) | 1 action disclosed | FDD Item 3 |
| Item 5 | Initial Franchise Fee | The Initial Franchise Fee is $49,500 (Item 5, p.17). | FDD Item 5 |
| Item 5 | Development Fee | No separate development fee disclosed. Multi-territory program discounts additional territories: second $40,000, third $35,000, fourth or additional $30,000. | FDD Item 5 |
| Item 6 | Royalty Fee | Greater of 7% of Gross Sales and the applicable Minimum Royalty. Minimum Royalty: $500 per month months 1-12, $1,000 months 13-24, $1,500 thereafter. | FDD Item 6 |
| Item 6 | National Media Fund | Pro | FDD Item 6 |
| Item 6 | Corporate Ad & Development Fund | Pro | FDD Item 6 |
| Item 6 | Total Ongoing Fee Burden | Pro | Calculated (Item 6) |
| Item 7 | Total Investment (low) | $148,400 | FDD Item 7 |
| Item 7 | Total Investment (high) | $211,725 | FDD Item 7 |
| Item 8 | Required Purchases (food/supplies) | Pro | FDD Item 8 |
| Item 11 | Franchisor Assistance | Pro | FDD Item 11 |
| Item 12 | Exclusive Territory | Pro | FDD Item 12 |
| Item 12 | Territory Size | Pro | FDD Item 12 |
| Item 15 | Operating Participation | Pro | FDD Item 15 |
| Item 17 | Initial Term Length | Pro | FDD Item 17(a) |
| Item 17 | Renewal Terms | Pro | FDD Item 17(b)-(c) |
| Item 17 | Required Remodel at Renewal | Pro | FDD Item 17(c) |
| Item 17 | Termination Triggers | Pro | FDD Item 17(f)-(h) |
| Item 17 | Transfer Fee | Pro | FDD Item 17(m), Item 6 |
| Item 17 | ROFR Provisions | Pro | FDD Item 17(n) |
| Item 17 | Post-Termination Non-Compete | Pro | FDD Item 17(r) |
| Item 19 | Revenue Metric Disclosed | Yes: Average Unit Metric $708,411 / Median Unit Metric $469,316 | FDD Item 19 |
| Item 20 | Total Franchised Units (2025) | 18 franchised outlets at end of 2025. | FDD Item 20 |
| Item 20 | Company-Owned Units (2025) | 0 company-owned outlets at end of 2025 (3 company-owned in 2023, all sold to franchisees by end of 2024). | FDD Item 20 |
| Item 20 | Total System Net Unit Growth (YoY) | +12 total outlets in 2025. | FDD Item 20 |
| Item 20 | Terminations | Pro | FDD Item 20 |
| Item 20 | Agreements Signed, Not Yet Open | Pro | FDD Item 20 |
| Item 21 | Audited Financials | Pro | FDD Item 21 |
Each signal turns one part of the filing into a read a buyer can act on. Strength means the disclosed data is favorable. In Line means it is typical for the category. Deal-Specific means the term is populated but you still have to model it against your own deal. Concern means the disclosed data is a real risk. The read is free. The reasoning behind it is the Pro read.
Item 19 earnings data is disclosed for Mold Medics. The full disclosure is free below; Zorzee's read of what it means stays in Pro.
Mold Medics trajectory is shown only where source-backed. Missing Item 20 fields stay blank inside the locked layout instead of removing the section.
Source: FDD Item 20 where present. Total system units, franchised plus company-owned. Not financial advice.
1 action disclosed in FDD Item 3. Case-level detail remains locked in Pro.
Zorzee editorial. Independent analysis. No franchisor review or approval. Not financial advice.
The filing tells you what Mold Medics costs to open. Pro adds the read on whether the numbers work for you, in your market, and whether this brand is a business or a job you bought.
Four months of research and more confused than when you started?
You've seen the filings and the numbers. What none of it tells you is whether this is a business that fits your money and your life. That is what fifteen minutes with a Zorzee-approved independent Franchise Consultant is for: whether this brand belongs on your shortlist, and what to validate before it does. Working with one costs you nothing and carries no obligation. Your franchise fee is the same whether you use one or not.
A Zorzee-approved Franchise Consultant never charges you. A franchisor pays the consultant a commission only if and when you decide to invest in a franchise they introduced you to. The analysis on this page earned nothing the moment you read it, no matter what you do next. That firewall is structural, not a promise: Zorzee's editorial earns no commission from franchise placements.
Zorzee earns no commission from franchise placements.
More for Pro readers: Browse the Signal Tracker library and get The Zorzee Report Pro.
A Mold Medics franchise costs $148,400 to $211,725 to open, disclosed in FDD Item 7 of the 2026 filing, covering the franchise fee, buildout, equipment, and working capital to breakeven. No commissions, no franchisor revenue, independent analysis only.
Mold Medics uses a Variable fee model fee structure, disclosed in FDD Item 6.
Item 19 for Mold Medics discloses an average unit volume of $708,411 (median $469,316) in the 2026 FDD. The figure is gross sales, not profit. Zorzee's read of what it excludes is in the Pro dossier.
Mold Medics's average unit volume is $708,411 (median $469,316) in the 2026 FDD. The figure is gross sales, not profit. Zorzee's read of what it excludes is in the Pro dossier.
Mold Medics's FDD Item 3 discloses 1 legal action. A raw count means little without scale and time, so weigh it against the system's 18 total outlets at end of 2025. units and the years covered. The case-level detail is the Pro read.
Zorzee does not rate franchises good or bad; it reports what the filing discloses so you can judge fit. Mold Medics shows Deal-Specific reads on Fee Structure, Unit Economics, Operator Validation, and Term & Exit Terms, In Line on Litigation History. Whether it fits depends on your capital, your market, and your operating style. Independent analysis, no franchisor revenue.